Latest MRTX reports update at 2023-11-06: 2023-Q32022-Q42022-Q3
Mirati Therapeutics logo
Mirati Therapeutics MRTX
$ 58.7 0.0%

Mirati Therapeutics Operating Expenses 2011-2024 | MRTX

Annual Operating Expenses Mirati Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
772 M 645 M 383 M 225 M 116 M 71.5 M 83.8 M 64.7 M 38.8 M 30.9 M - 12.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
772 M 12.8 M 222 M

Quarterly Operating Expenses Mirati Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
188 M 201 M 201 M - 192 M 183 M 185 M - 151 M 164 M 132 M - 100 M 84.9 M 89.8 M - 58 M 48.2 M 44 M - 28.9 M 28.7 M 24.8 M - 16.6 M 18.6 M 18.1 M - 19.6 M 22.2 M 22.1 M - 18.7 M 15.5 M 12 M - 10.5 M 10.1 M 7.98 M - 9.21 M 6.89 M 8 M - 5.97 M 4.73 M - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
201 M 4.73 M 66.6 M